Loading...

Revvity, Inc.

RVTYNYSE
Healthcare
Medical - Diagnostics & Research
$103.67
$1.70(1.67%)

Revvity, Inc. (RVTY) Stock Overview

Explore Revvity, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.4/100

Key Financials

Market Cap12.2B
P/E Ratio43.58
EPS (TTM)$2.42
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Week$90.19
1 Month$84.61
3 Months$111.73
1 Year Target$128.24

RVTY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Revvity, Inc. (RVTY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $128.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.58 and a market capitalization of 12.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;